Published in J Atheroscler Thromb on April 05, 2016
MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling. Int J Mol Sci (2016) 0.77
Subsequent Response of VWF and ADAMTS13 to Aortic Valve Replacement. J Atheroscler Thromb (2016) 0.75
Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant (2012) 11.34
Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med (2003) 5.33
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr (2009) 4.69
Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem (2001) 3.02
Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet (1992) 2.95
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest (1980) 2.88
Vertical agarose gel electrophoresis and electroblotting of high-molecular-weight proteins. Electrophoresis (2003) 2.46
Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood (2006) 2.36
Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy. J Atheroscler Thromb (2014) 1.61
Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index. J Atheroscler Thromb (2015) 1.60
von Willebrand factor: two sides of a coin. J Thromb Haemost (2005) 1.37
Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion (2006) 1.28
Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients. Atherosclerosis (2009) 1.24
The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure? Curr Mol Med (2010) 1.16
The association of unexplained gastrointestinal bleeding with calcific aortic stenosis. Ann Thorac Surg (1987) 1.11
Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood (2007) 1.07
Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost (1990) 0.99
An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology (2013) 0.94
Colonic vascular ectasias and aortic stenosis: coincidence or causal relationship? Am J Surg (1986) 0.94
Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow. Blood (2002) 0.86
Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis. Thromb Haemost (2009) 0.85
Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost (2002) 0.83
Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels. Bone Marrow Transplant (2007) 0.81
Impairment of platelet retention rate in patients with severe aortic valve stenosis. J Cardiol (2013) 0.80
Platelets treated with ticlopidine are less reactive to unusually large von Willebrand factor multimers than are those treated with aspirin under high shear stress. Pathophysiol Haemost Thromb (2005) 0.79
Adhesive Forces between A1 Domain of von Willebrand Factor and N-terminus Domain of Glycoprotein Ibα Measured by Atomic Force Microscopy. J Atheroscler Thromb (2015) 0.79
Prediction of Molecular Interaction between Platelet Glycoprotein Ibα and von Willebrand Factor using Molecular Dynamics Simulations. J Atheroscler Thromb (2015) 0.78
Aortic stenosis, von Willebrand factor, and bleeding. N Engl J Med (2003) 0.77
Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A (2002) 2.23
ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage. Blood (2003) 2.06
Autopsy case of sudden maternal death from thrombotic thrombocytopenic purpura. J Obstet Gynaecol Res (2012) 1.96
ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion. Blood (2009) 1.89
Localization of ADAMTS13 to the stellate cells of human liver. Blood (2005) 1.85
SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood (2002) 1.59
VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood (2003) 1.55
Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesth Analg (2005) 1.54
Engineering bioartificial tracheal tissue using hybrid fibroblast-mesenchymal stem cell cultures in collagen hydrogels. Interact Cardiovasc Thorac Surg (2010) 1.46
Reasonable and effective volume reduction of a giant left atrium associated with mitral valve disease. Ann Thorac Cardiovasc Surg (2008) 1.45
Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis. Thromb Haemost (2008) 1.45
Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology. Pediatr Nephrol (2006) 1.43
A murine model of acute liver injury induced by human monoclonal autoantibody. Hepatology (2005) 1.43
[Case of thrombotic thrombocytopenic purpura associated with clopidogrel]. Rinsho Shinkeigaku (2007) 1.37
Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb Haemost (2009) 1.33
Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis (2003) 1.30
Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion (2006) 1.28
Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. Intern Med (2010) 1.27
Potential roles of large mafs in cell lineages and developing pancreas. Pancreas (2006) 1.27
Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow. J Exp Med (2006) 1.21
Ectopic pancreas in the anterior mediastinum. Jpn J Thorac Cardiovasc Surg (2005) 1.13
High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol (2003) 1.12
Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Mol Immunol (2013) 1.10
Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome. Blood (2003) 1.10
Rolling of Th1 cells via P-selectin glycoprotein ligand-1 stimulates LFA-1-mediated cell binding to ICAM-1. J Immunol (2005) 1.09
Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood (2007) 1.07
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost (2012) 1.06
Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol (2002) 1.06
Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Transfusion (2002) 1.03
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol (2008) 1.03
Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status. Int J Oncol (2010) 1.01
Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute renal failure. Nephrol Dial Transplant (2006) 1.00
Glucose-induced production of hydrogen sulfide may protect the pancreatic beta-cells from apoptotic cell death by high glucose. FEBS Lett (2008) 1.00
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl (2009) 1.00
Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor. Intern Med (2010) 1.00
Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol (2008) 0.99
CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Int Immunol (2008) 0.98
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol (2007) 0.97
Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura. Blood (2004) 0.96
Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy. Clin Exp Nephrol (2012) 0.95
The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Semin Hematol (2004) 0.95
Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation. Int J Hematol (2014) 0.95
A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J Immunol (2003) 0.94
Two-state conformations in the hyaluronan-binding domain regulate CD44 adhesiveness under flow condition. Structure (2010) 0.93
Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura. J Hepatol (2005) 0.93
Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol (2002) 0.92
ADAMTS13 safeguards the myocardium in a mouse model of acute myocardial infarction. Thromb Haemost (2012) 0.91
Off-pump quintuple coronary artery bypass grafting for situs inversus totalis. Jpn J Thorac Cardiovasc Surg (2004) 0.91
Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis. Scand J Gastroenterol (2008) 0.91
Aortopulmonary fistula due to perforation of the aortic wall of a freestyle stentless valve. Ann Thorac Surg (2004) 0.90
Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer. Jpn J Clin Oncol (2010) 0.90
Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein. J Rheumatol (2002) 0.90
Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood (2002) 0.90
Platelet shape changes and adhesion under high shear flow. Arterioscler Thromb Vasc Biol (2002) 0.89
Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling. Int Immunol (2004) 0.89
Calpain inhibitor-1 protects the rat heart from ischemia-reperfusion injury: analysis by mechanical work and energetics. Am J Physiol Heart Circ Physiol (2004) 0.89
Video-assisted thoracoscopic surgery is a promising treatment for solitary fibrous tumor of the pleura. Chest (2004) 0.88
An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation. Blood (2008) 0.88
Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels (2008) 0.88
Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer. Biochemistry (2002) 0.88
The effect of mesenchymal stem cell osteoblastic differentiation on the mechanical properties of engineered bone-like tissue. Tissue Eng Part A (2011) 0.87
Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol (2010) 0.87
Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban. Am J Physiol Heart Circ Physiol (2008) 0.87
Actin assembly controlled by GDP-Rab27a is essential for endocytosis of the insulin secretory membrane. Arch Biochem Biophys (2010) 0.87
Thrombotic thrombocytopenic purpura associated with pegylated-interferon alpha-2a by an ADAMTS13 inhibitor in a patient with chronic hepatitis C. Haematologica (2006) 0.87
Effective enhancement of X-ray-induced apoptosis in human cancer cells with mutated p53 by siRNA targeting XIAP. Oncol Rep (2008) 0.86
[Surgical repair of a large isolated internal iliac artery aneurysm presenting with acute renal failure. A case report]. Nihon Geka Gakkai Zasshi (2004) 0.86